Alnylam Pharma
ALNY----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Alnylam Pharma(ALNY) predict that the Revenue is 1.167 B (+96.43%), Beat estimate;the EBIT is 268.64 M (+1386%), Beat estimate;the EPS is 1.51 (+443.2%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
1.17B96.43%
1.12B87.92%
+0.05B8.51%
EBITExceed expectations
0.27B1386.07%
0.14B686.65%
+0.13B699.42%
EPSExceed expectations
1.51443.18%
0.9063305.98%
+0.6037137.20%
Upcoming earnings report - FY2026 Q2 Earning Release
Available dateJul 30, 2026
Estimate Revenue1.322 B
Estimate EBIT277.95 M
Estimate EPS1.6366
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf